BENFAREMO, Devis
 Distribuzione geografica
Continente #
NA - Nord America 4.684
EU - Europa 1.930
AS - Asia 1.692
SA - Sud America 341
Continente sconosciuto - Info sul continente non disponibili 254
AF - Africa 139
OC - Oceania 3
Totale 9.043
Nazione #
US - Stati Uniti d'America 4.540
IT - Italia 670
SG - Singapore 560
VN - Vietnam 358
CN - Cina 305
RU - Federazione Russa 304
BR - Brasile 255
HK - Hong Kong 153
IE - Irlanda 132
DE - Germania 131
UA - Ucraina 127
SE - Svezia 119
FR - Francia 113
GB - Regno Unito 105
BD - Bangladesh 63
IN - India 62
CI - Costa d'Avorio 60
CA - Canada 56
FI - Finlandia 54
NL - Olanda 36
MX - Messico 32
DK - Danimarca 31
TR - Turchia 31
JP - Giappone 28
MA - Marocco 27
AR - Argentina 26
PL - Polonia 26
AT - Austria 22
KR - Corea 22
IQ - Iraq 19
ZA - Sudafrica 19
CO - Colombia 17
ES - Italia 12
LT - Lituania 12
TW - Taiwan 12
BE - Belgio 11
EC - Ecuador 11
GT - Guatemala 9
NI - Nicaragua 9
PH - Filippine 9
UZ - Uzbekistan 9
VE - Venezuela 9
CR - Costa Rica 8
SA - Arabia Saudita 8
TN - Tunisia 8
CL - Cile 7
ID - Indonesia 7
EG - Egitto 6
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
OM - Oman 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
CH - Svizzera 5
GR - Grecia 5
HN - Honduras 5
PK - Pakistan 5
JO - Giordania 4
MY - Malesia 4
PR - Porto Rico 4
SV - El Salvador 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
PE - Perù 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CW - ???statistics.table.value.countryCode.CW??? 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RO - Romania 1
SI - Slovenia 1
Totale 8.787
Città #
Ashburn 854
Singapore 351
Chandler 331
Dallas 211
San Jose 207
Fairfield 173
Council Bluffs 166
Hong Kong 149
Jacksonville 140
New York 133
Dublin 129
Des Moines 120
Ho Chi Minh City 120
Boardman 92
Los Angeles 92
Hanoi 86
Wilmington 85
Woodbridge 82
Beijing 79
Seattle 79
Houston 75
Ancona 68
Centro 63
Lauterbourg 62
The Dalles 62
Abidjan 60
Moscow 60
Milan 51
Munich 51
Lawrence 49
Princeton 49
Ann Arbor 46
Cambridge 44
Santa Clara 42
Redmond 40
Orem 35
San Mateo 33
Buffalo 32
Rome 32
São Paulo 32
Chicago 29
Phoenix 28
Brooklyn 26
London 26
Haiphong 25
Turin 25
Atlanta 24
San Diego 24
Helsinki 23
Tolentino 23
Warsaw 23
Montreal 21
Washington 21
Hefei 19
Chennai 18
Denver 18
Frankfurt am Main 18
Turku 18
Tokyo 15
Johannesburg 14
Manchester 14
Poplar 13
San Francisco 13
Da Nang 12
Pune 12
Amsterdam 11
Irvington 11
Naples 11
Boston 10
Brussels 10
Columbus 10
Iesi 10
Nuremberg 10
Brasília 9
Marche 9
Mexico City 9
Tashkent 9
Baghdad 8
Cagliari 8
Guangzhou 8
Guatemala City 8
Monte San Pietrangeli 8
Mumbai 8
North Bergen 8
Norwalk 8
Palermo 8
Shanghai 8
Stockholm 8
Vienna 8
Vilnius 8
Wuhan 8
Belo Horizonte 7
Charlotte 7
Miano 7
Newark 7
Querétaro 7
South Pasadena 7
St Louis 7
Amandola 6
Bắc Ninh 6
Totale 5.459
Nome #
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 327
Diagnosis and management of leukocytoclastic vasculitis 224
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 210
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 201
ACCURACY OF DUAL-ENERGY COMPUTED TOMOGRAPHY FOR THE DETECTION OF BONE MARROW EDEMA IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS 198
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 191
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 185
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 175
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 175
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 174
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 172
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 169
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 163
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 159
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 157
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 157
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 156
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 154
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 149
Certolizumab pegol for the treatment of psoriasis 148
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 147
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 142
A painful diagnosis 141
Videofluorography swallow study in patients with systemic sclerosis: correlation with clinical and radiological features 139
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 138
Biologics in inflammatory immune-mediated systemic diseases 138
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 138
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 135
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis 133
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 131
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 130
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 128
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 127
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association 127
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 123
Patient reported outcomes and assessment of the quality of life in a cohort of patients affected by enteropathic spondyloarthritis: results of a monocentric prospective observational study at one year 122
Putative functional pathogenic autoantibodies in systemic sclerosis 122
Biologics in inflammatory and immunomediated arthritis 118
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 114
A young man with persistent dyspepsia: The unexpected virtue of proton-pump inhibitors 112
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 109
Dolore Articolare Acuto 105
Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature 105
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 104
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine 104
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 103
Hypogammaglobulinemia in patients affected by limited cutaneous systemic sclerosis: Case series and review of the literature 102
Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosis 102
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 102
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 99
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 97
Current take on systemic sclerosis patients’ vaccination recommendations 96
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study 95
Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study 93
Pre-scleroderma and new opportunities for preventive medicine 92
Novel therapeutic approaches and treatment targets for psoriatic arthritis 92
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19) 91
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients 90
Role of cognitive impairment and malnutrition as determinants of quality of life in patients with systemic sclerosis 88
Systemic Sclerosis: A Key Model of Endothelial Dysfunction 84
Widespread painful nodules in a patient with rheumatoid arthritis 84
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 83
Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia 83
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 80
Is there a future for anti-cd38 antibody therapy in systemic autoimmune diseases? 79
Tocilizumab for severe COVID-19 pneumonia 74
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 71
Skin ultrasound in systemic sclerosis: past, present and exciting future 68
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 53
Exploring potential VEGF receptor 2 inhibitors: a molecular modeling and pharmacophore-based screening approach 42
Expert Perspectives: Defining and managing progressive pulmonary fibrosis in systemic sclerosis 33
Micro- and Macro-Vascular Disease in Systemic Sclerosis and Very Early SSc (VEDOSS): Results from a Monocentric Observational Study 32
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study 26
The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint-gut remission: Four-year outcomes from the real-world SPIB cohort 25
Predictors of response and long-term efficacy and safety of Nintedanib in Systemic Sclerosis-Interstitial Lung Disease: data from an Italian multicentre study 8
Totale 9.043
Categoria #
all - tutte 42.688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.688


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022294 0 0 0 6 9 40 6 14 32 36 78 73
2022/2023898 68 103 67 79 44 201 11 53 187 10 59 16
2023/2024622 70 14 51 63 86 139 25 26 9 80 14 45
2024/20251.288 177 91 20 32 68 60 170 58 216 70 149 177
2025/20263.617 287 207 198 335 438 245 579 359 299 332 155 183
2026/20271.087 415 134 178 360 0 0 0 0 0 0 0 0
Totale 9.043